Evidence map›Paper›PMID 35074016›Full record

ArticleInfectious diseases of poverty2022

Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad.

Kat S Rock, Ching-I Huang, Ronald E Crump, Paul R Bessell, Paul E Brown, Inaki Tirados, Philippe Solano, Marina Antillon, Albert Picado, Severin Mbainda and 4 more

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Modeling framework to demonstrate elimination of a vector population: Tsetse elimination in Chad.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  7. Using Passive Surveillance to Maintain Elimination as a Public Health Problem for Neglected Tropical Diseases: A Model-Based Exploration.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. [Towards elimination of human African trypanosomiasis].Medecine tropicale et sante internationale · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Kat S RockMathematics Institute, University of Warwick, Academic Loop Road, Coventry, CV4 7AL, UK. k.s.rock@warwick.ac.uk.ORCID http://orcid.org/0000-0001-8414-7648
Ching-I HuangMathematics Institute, University of Warwick, Academic Loop Road, Coventry, CV4 7AL, UK.ORCID http://orcid.org/0000-0002-8329-8310
Ronald E CrumpMathematics Institute, University of Warwick, Academic Loop Road, Coventry, CV4 7AL, UK.ORCID http://orcid.org/0000-0002-9884-4900
Paul R BessellIndependent Consultant, Edinburgh, UK.ORCID http://orcid.org/0000-0002-7901-969X
Paul E BrownMathematics Institute, University of Warwick, Academic Loop Road, Coventry, CV4 7AL, UK.ORCID http://orcid.org/0000-0002-8764-4583
Inaki TiradosDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID http://orcid.org/0000-0002-9771-4880
Philippe SolanoInstitut de Recherche pour le Développement, UMR INTERTRYP IRD-CIRAD, Université de Montpellier, 34398, Montpellier, France.ORCID http://orcid.org/0000-0002-4351-3506
Marina AntillonSwiss Tropical and Public Health Institute, Basel, Switzerland.ORCID http://orcid.org/0000-0002-0235-6030
Albert PicadoFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.ORCID http://orcid.org/0000-0001-7344-628X
Severin MbaindaProgramme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Moundou, Chad.
Justin DarnasProgramme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Moundou, Chad.
Emily H CrowleyMathematics Institute, University of Warwick, Academic Loop Road, Coventry, CV4 7AL, UK.ORCID http://orcid.org/0000-0002-5121-4979
Steve J TorrDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID http://orcid.org/0000-0001-9550-4030
Mallaye PekaProgramme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA), Moundou, Chad.
University of Warwick · GBLiverpool School of Tropical Medicine · GBCentre de Coopération Internationale en Recherche Agronomique pour le Développement · FRFIND · CHSwiss Tropical and Public Health Institute · CH

Funding

Biotechnology and Biological Sciences Research Council BB/P005888/1Biotechnology and Biological Sciences Research Council BB/S00243X/1Biotechnology and Biological Sciences Research Council BB/S01375X/1Gates Foundation INV-005121Gates Foundation INV-008412
6 · The paper itself

Abstract

backgroundIn recent years, a programme of vector control, screening and treatment of gambiense human African trypanosomiasis (gHAT) infections led to a rapid decline in cases in the Mandoul focus of Chad. To represent the biology of transmission between humans and tsetse, we previously developed a mechanistic transmission model, fitted to data between 2000 and 2013 which suggested that transmission was interrupted by 2015. The present study outlines refinements to the model to: (1) Assess whether elimination of transmission has already been achieved despite low-level case reporting; (2) quantify the role of intensified interventions in transmission reduction; and (3) predict the trajectory of gHAT in Mandoul for the next decade under different strategies.

methodOur previous gHAT transmission model for Mandoul was updated using human case data (2000-2019) and a series of model refinements. These include how diagnostic specificity is incorporated into the model and improvements to the fitting method (increased variance in observed case reporting and how underreporting and improvements to passive screening are captured). A side-by-side comparison of fitting to case data was performed between the models.

resultsWe estimated that passive detection rates have increased due to improvements in diagnostic availability in fixed health facilities since 2015, by 2.1-fold for stage 1 detection, and 1.5-fold for stage 2. We find that whilst the diagnostic algorithm for active screening is estimated to be highly specific (95% credible interval (CI) 99.9-100%, Specificity = 99.9%), the high screening and low infection levels mean that some recently reported cases with no parasitological confirmation might be false positives. We also find that the focus-wide tsetse reduction estimated through model fitting (95% CI 96.1-99.6%, Reduction = 99.1%) is comparable to the reduction previously measured by the decline in tsetse catches from monitoring traps. In line with previous results, the model suggests that transmission was interrupted in 2015 due to intensified interventions.

conclusionsWe recommend that additional confirmatory testing is performed in Mandoul to ensure the endgame can be carefully monitored. More specific measurement of cases, would better inform when it is safe to stop active screening and vector control, provided there is a strong passive surveillance system in place.

Indexed as

Trypanosomiasis, AfricanAnimalsChadHumansMass ScreeningTrypanosoma brucei gambienseDiagnosticsElimination of transmissionGambiense human African trypanosomiasis (gHAT)GlossinaModellingTsetseValidationVector control

Identifiers

PMID35074016
PMCPMC8785021
OpenAlexW4226400050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.